Literature DB >> 14654573

Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention.

V K Podichetty1, D J Mazanec, R S Biscup.   

Abstract

Musculoskeletal pain is common, frequently under-reported, and inadequately treated in the older adult. The objective of this article is to review the management of musculoskeletal pain syndromes in older adults emphasising the potential role of opioid agents in carefully selected patients. Systematic analysis of the relevant literature was done. Even in cognitively impaired patients, assessment of musculoskeletal pain is mandatory. An algorithm for musculoskeletal pain is presented emphasising a stepwise pharmacological approach in combination with an array of non-pharmacological therapies. Comorbid conditions may limit therapeutic choices, particularly in the elderly. Repeated assessment of pain levels as well as functional status is critical for optimal pain management.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654573      PMCID: PMC1742882          DOI: 10.1136/pmj.79.937.627

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  76 in total

1.  Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

Authors:  R C Lawrence; C G Helmick; F C Arnett; R A Deyo; D T Felson; E H Giannini; S P Heyse; R Hirsch; M C Hochberg; G G Hunder; M H Liang; S R Pillemer; V D Steen; F Wolfe
Journal:  Arthritis Rheum       Date:  1998-05

2.  Empirical evidence of the association between the presence of musculoskeletal pain and physical disability in community-dwelling senior citizens.

Authors:  R J Scudds; J McD Robertson
Journal:  Pain       Date:  1998-04       Impact factor: 6.961

Review 3.  Should people taking opioids for medical reasons be allowed to work and drive?

Authors:  J P Zacny
Journal:  Addiction       Date:  1996-11       Impact factor: 6.526

4.  Outcome of chronic opioid therapy for non-cancer pain.

Authors:  J A Haythornthwaite; L A Menefee; A L Quatrano-Piacentini; M Pappagallo
Journal:  J Pain Symptom Manage       Date:  1998-03       Impact factor: 3.612

Review 5.  NSAIDs and the elderly. Toxicity and economic implications.

Authors:  A C Phillips; R P Polisson; L S Simon
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

6.  Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus.

Authors:  T A Bamigbade; C Davidson; R M Langford; J A Stamford
Journal:  Br J Anaesth       Date:  1997-09       Impact factor: 9.166

7.  Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers.

Authors:  Molke F Borgbjerg; Kurt Nielsen; Jan Franks
Journal:  Pain       Date:  1996-01       Impact factor: 6.961

8.  A systematic review of antidepressants in neuropathic pain.

Authors:  H J McQuay; M Tramèr; B A Nye; D Carroll; P J Wiffen; R A Moore
Journal:  Pain       Date:  1996-12       Impact factor: 6.961

Review 9.  Recent considerations in nonsteroidal anti-inflammatory drug gastropathy.

Authors:  G Singh
Journal:  Am J Med       Date:  1998-07-27       Impact factor: 4.965

10.  Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology.

Authors:  R Bernabei; G Gambassi; K Lapane; F Landi; C Gatsonis; R Dunlop; L Lipsitz; K Steel; V Mor
Journal:  JAMA       Date:  1998-06-17       Impact factor: 56.272

View more
  24 in total

1.  Chiropractic science: a contemporary neurophysiologic paradigm.

Authors:  John Srbely
Journal:  J Can Chiropr Assoc       Date:  2010-09

2.  Prescription use disorders in older adults.

Authors:  Raj K Kalapatapu; Maria A Sullivan
Journal:  Am J Addict       Date:  2010-09-21

Review 3.  A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs.

Authors:  Charles E Argoff; Daniel I Silvershein
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

4.  A Pilot Randomized Controlled Trial of the Effects of Chair Yoga on Pain and Physical Function Among Community-Dwelling Older Adults With Lower Extremity Osteoarthritis.

Authors:  Juyoung Park; Ruth McCaffrey; David Newman; Patricia Liehr; Joseph G Ouslander
Journal:  J Am Geriatr Soc       Date:  2016-12-23       Impact factor: 5.562

Review 5.  New trends in the treatment and management of myofascial pain syndrome.

Authors:  John Z Srbely
Journal:  Curr Pain Headache Rep       Date:  2010-10

Review 6.  Effects of treatment of myofascial trigger points on the pain of fibromyalgia.

Authors:  Maria Adele Giamberardino; Giannapia Affaitati; Alessandra Fabrizio; Raffaele Costantini
Journal:  Curr Pain Headache Rep       Date:  2011-10

7.  Management of persistent pain in older adults: the MOBILIZE Boston Study.

Authors:  Carrie Stewart; Suzanne G Leveille; Robert H Shmerling; Elizabeth J Samelson; Jonathan F Bean; Pat Schofield
Journal:  J Am Geriatr Soc       Date:  2012-11-05       Impact factor: 5.562

Review 8.  Co-occurrence of pain syndromes.

Authors:  Giannapia Affaitati; Raffaele Costantini; Claudio Tana; Francesco Cipollone; Maria Adele Giamberardino
Journal:  J Neural Transm (Vienna)       Date:  2019-11-29       Impact factor: 3.575

9.  Efficacy and tolerability of tapentadol for the treatment of chronic low back pain in elderly patients.

Authors:  Ulderico Freo; Maurizio Furnari; Francesco Ambrosio; Paolo Navalesi
Journal:  Aging Clin Exp Res       Date:  2020-05-16       Impact factor: 3.636

10.  Frequency and Associations of Prescription Nonsteroidal Anti-inflammatory Drug Use Among Patients With a Musculoskeletal Disorder and Hypertension, Heart Failure, or Chronic Kidney Disease.

Authors:  Zachary Bouck; Graham C Mecredy; Noah M Ivers; Moumita Barua; Danielle Martin; Peter C Austin; Joshua Tepper; R Sacha Bhatia
Journal:  JAMA Intern Med       Date:  2018-11-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.